These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3364932)
21. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276 [TBL] [Abstract][Full Text] [Related]
22. Intraoperative localization of malignant pheochromocytoma by 123-I-metaiodobenzylguanidine single probe measurement. Lehnert H; Weber P; Nägele-Wöhrle B; von Bülow M; Eissner D; Schweden F; Junginger T; Schrezenmeir J; Krause U; Beyer J Klin Wochenschr; 1988 Jan; 66(2):61-4. PubMed ID: 3347006 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging. Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024 [TBL] [Abstract][Full Text] [Related]
24. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy]. Yokoyama H; Tsuji Y Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357 [TBL] [Abstract][Full Text] [Related]
25. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058 [TBL] [Abstract][Full Text] [Related]
26. [131I-MIBG scintigraphy in diagnosing pheochromocytoma]. Huang MJ; Tzen KY; Chen HY; Kao PF Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):781-7. PubMed ID: 3681245 [No Abstract] [Full Text] [Related]
27. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Shulkin BL; Koeppe RA; Francis IR; Deeb GM; Lloyd RV; Thompson NW Radiology; 1993 Mar; 186(3):711-5. PubMed ID: 8430179 [TBL] [Abstract][Full Text] [Related]
29. Comparison of 131I-metaiodobenzylguanidine scintigraphy with urinary and plasma catecholamine determinations in the diagnosis of pheochromocytoma. Plewe G; Beyer J; Krause U; Cordes U; Eissner D; Hahn K Klin Wochenschr; 1985 Jul; 63(14):627-30. PubMed ID: 4032986 [TBL] [Abstract][Full Text] [Related]
30. [A case of familial, benign, recurrent and multiple pheochromocytoma whose 131I-MIBG scintigraphy was false negative]. Shimizu H; Kondo M; Yuzuki Y; Shimono Y; Yagi M; Arai K Rinsho Hoshasen; 1989 Sep; 34(9):1055-8. PubMed ID: 2810836 [TBL] [Abstract][Full Text] [Related]
31. Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT. Nielsen JT; Nielsen BV; Rehling M Clin Nucl Med; 1996 Sep; 21(9):695-9. PubMed ID: 8879869 [TBL] [Abstract][Full Text] [Related]
32. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032 [TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of pheochromocytoma by I-131 MIBG scintigraphy]. Hayashida K; Nishimura T; Uehara T; Imakita M; Yutani C Rinsho Hoshasen; 1986 Jan; 31(1):49-54. PubMed ID: 3702112 [No Abstract] [Full Text] [Related]
34. Usefulness of scintigraphic imaging using 131iodine-metaiodobenzylguanidine in localization of asymptomatic pheochromocytoma. Yazaki T; Uchida K; Kaneko S; Tomomasa H; Ishikawa H; Kanoh S; Koiso K; Ishikawa N J Urol; 1985 Jul; 134(1):107-9. PubMed ID: 4009800 [TBL] [Abstract][Full Text] [Related]
35. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma. Greenblatt DY; Shenker Y; Chen H Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324 [TBL] [Abstract][Full Text] [Related]
36. [131I-metaiodobenzylguanidine scintigraphy for the detection of pheochromocytoma]. Koizumi M; Endo K; Sakahara H; Nakashima T; Kawamura Y; Ohta H; Nakano Y; Torizuka K Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Jul; 46(7):946-52. PubMed ID: 3797227 [No Abstract] [Full Text] [Related]
37. [131-I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma]. Nakanishi F; Kasuga T; Sakai Y; Sone S; Watanabe T; Imai Y; Ito K; Yamashita K; Yano K Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Dec; 47(12):1579-87. PubMed ID: 3452791 [No Abstract] [Full Text] [Related]
38. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis. Lev I; Kelekar G; Waxman A; Yu R Endocr Pract; 2010; 16(3):398-407. PubMed ID: 20061293 [TBL] [Abstract][Full Text] [Related]
39. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome. Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305 [TBL] [Abstract][Full Text] [Related]